Frequently Asked Questions
Is this safe with my HRT? Where do the peptides come from? What happens in the consultation? We've answered the questions that gate a real decision — plainly, without the marketing gloss.
Cluster 01
The biology questions. Medications, contraindications, labs, and why women 40+ require a different approach.
For most women, yes. BPC-157, CJC-1295, Epitalon, and MOTS-c do not directly compete with exogenous estrogen or progesterone — they work on separate biological pathways. That said, our intake reviews your full approach at intake and will note any interactions specific to your HRT dose and formulation.
The intake review exists precisely for this conversation. If you're on HRT, bring your current formulation and dose — the more precise your intake, the better your intake review can calibrate the approach around it. → Read about our approach
→ Read the dedicated peptides-and-HRT page for the full sequencing framework
Possibly — this is exactly what the intake review is designed to evaluate. SSRIs and thyroid medications generally don't conflict with the peptides we use, but dose timing and your specific health picture matter.
GLP-1 agonists require a more careful look. The intake team will assess how metabolic peptides like MOTS-c interact with your current regimen before making a recommendation. Don't pre-disqualify yourself — let the intake review make that call. → Read about our framing
Yes. We do not enroll women who are pregnant, breastfeeding, or actively being treated for cancer. Active autoimmune conditions require careful evidence-based review — some peptides have immunomodulatory properties that may be contraindicated depending on your condition and current medications.
A history of hormone-sensitive cancers (breast, ovarian, uterine) requires explicit clinical curator clearance before any approach begins. These aren't bureaucratic hurdles — they're the reason clinical oversight exists. We'd rather decline an enrollment than create harm.
It depends on your approach. For the Longevity & Cellular Health approaches (Epitalon + MOTS-c), baseline metabolic and hormonal markers are strongly recommended. For Recovery & Vitality and Sleep & Restoration, recent labs are helpful but not always required.
Your intake review will specify what's needed after reviewing your intake. We can work with existing recent labs — you don't necessarily need a new draw before the consultation. → See the Longevity approach
Perimenopause changes how peptides work at a fundamental level. Declining estrogen and progesterone affect growth hormone pulsatility, muscle protein synthesis, deep sleep architecture, and mitochondrial efficiency — all things our approaches specifically address.
Dosing logic derived from studies on 30-year-old men is wrong for a 50-year-old woman's physiology. Our approaches are built around that reality, not retrofitted to it. → Read our full thesis or understand your stage
Cluster 02
What actually happens — process, timelines, and what it looks like at month 3 and beyond.
You complete a brief intake form covering your health history, current medications, hormonal stage, and goals. A research-backed clinical curator reviews your intake — typically within one business day — and either schedules a short call (15–20 minutes) or sends a written approach recommendation with rationale.
There's no obligation to proceed after the intake review. The goal is honest clarity: whether an approach is right for you, and if so, which one. → Read the approach
Each Eterna Femme approach addresses a different set of pathways, not a different price tier. Foundation approaches (BPC-157 + Ipamorelin for recovery; CJC-1295 for sleep) target one or two specific mechanisms. Multi-peptide approaches layer several mechanisms. Read the four approach pages, and to start from a symptom, see /start-here to read by area before your consultation.
Be honest with yourself about expectations. BPC-157 users often notice improved recovery and reduced inflammation within 2–4 weeks. CJC-1295 sleep benefits typically emerge over 3–6 weeks as GH pulse patterns normalize.
Epitalon and MOTS-c work on longer cellular timescales — most women notice meaningful changes at 8–12 weeks, with deeper benefits accumulating over months. We don't promise overnight results and won't pretend otherwise. → Recovery & Vitality details
If the intake review determines you're not an appropriate candidate during intake, you are not charged for an approach. If you start and experience adverse effects that warrant stopping, refund eligibility depends on what's been dispensed and how far into the cycle you are — your intake review team will work through this with you directly. We don't want your money if the approach isn't right for you.
We don't want your money if the approach isn't right for you. That's not a marketing claim — it's how a research-backed practice has to operate.
Insurance does not cover peptide approaches — these are cash-pay wellness programs. HSA and FSA eligibility varies: clinical curator consultation fees are generally HSA/FSA-eligible as a qualified medical expense; the peptide compounds themselves may or may not qualify depending on your plan administrator.
We recommend confirming with your benefits administrator. We provide itemized receipts that distinguish the intake review consultation component from the peptide supply — which may help with HSA/FSA submissions.
Month 3 is a structured clinical curator check-in: we review your reported outcomes, adjust dosing if warranted, and decide whether to continue as-is, modify the approach, or add a complementary peptide.
Month 6 is a more comprehensive review — labs may be repeated, and you and your clinical curator will make an explicit decision about the next phase. Most women who are responding well at month 3 see compounding benefit through month 6 and beyond. The clinical relationship doesn't end at intake. → Get the free Primer guide
Cluster 03
Where the peptides come from, how to verify they're real, and what separates this from gray-market alternatives.
Our peptides are sourced through licensed compounding pharmacies operating under clinical curator prescription — not gray-market research-chemical suppliers. Each batch is third-party tested for identity, purity, and potency before dispensing.
The compounding pharmacy model means your peptides are prepared to pharmaceutical standards for your specific approach, not off-the-shelf vials from unverified sources. We can share testing documentation on request. → Our approach to quality
Three differences: clinical oversight, pharmaceutical-grade sourcing, and accountability. Research-chemical peptides sold online have no verified purity, no dosing guidance calibrated to your biology, no clinical curator reviewing contraindications, and no one to call if something goes wrong. Some are counterfeit. Some are contaminated.
Underdosed, mislabeled, or improperly prepared peptides from unverified sources can cause real harm. What we offer isn't a premium markup on the same product. It's a fundamentally different product category — with the clinical oversight to back it up.
Recovery & Vitality (BPC-157) — Cellular repair, tissue healing, and metabolic momentum. For women whose recovery from exercise, stress, and illness has visibly slowed.
Sleep & Restoration (CJC-1295) — Deep sleep architecture and overnight GH pulse. For women whose sleep quality has quietly shifted in their 40s — less restorative, harder to sustain.
Longevity & Cellular Health (Epitalon + MOTS-c) — Cellular aging, telomere biology, and mitochondrial efficiency. For women focused on healthspan over the long term.
The intake team will help you prioritize based on your current symptoms. Many women start with the approach that addresses their most pressing symptom and build from there. → Understand your stage
Stacking is possible — but requires evidence-based review to ensure the combination makes sense for your biology and doesn't create compound effects that need monitoring. Many women start with one approach, stabilize, then discuss adding a second with their clinical curator at 60–90 days.
Switching is straightforward — your intake review updates the plan and we handle the logistics. There are no lock-in penalties. We care about outcomes, not subscription retention. → Read the consultation walkthrough
Cluster 04
The questions that come up once you've placed yourself on the transition — how peptide work fits alongside HRT, what "physician-informed" actually means at 52, and how the site itself is shaped for where you are right now.
Peptide approaches and HRT don't do the same job, and they sit alongside each other rather than in place of each other. BPC-157, CJC-1295, Epitalon, and MOTS-c target tissue repair, deep sleep architecture, mitochondrial efficiency, and overnight recovery — pathways that exogenous estrogen or progesterone don't address.
Calibrating the order of the two with your own physician is part of the intake review conversation. → Read the peptides-and-HRT sequencing framework
→ Place yourself on the staging guide, or read the FAQ written for women 40+.
"Physician-informed" means a research-trained clinical curator with clinical oversight reviews every intake and is responsible for the recommendation. There is no prescribing physician on Eterna Femme's staff; the approaches are dispensed under clinical curator prescription through licensed compounding pharmacies.
A curator typically reviews your intake within one business day and either schedules a short call (15–20 minutes) or sends a written approach recommendation. The full framing lives at → our approach, with the women-40+ lens that shapes it at /faq-over-40.
Bring it up plainly — your physician belongs inside the care plan, not outside it. Print the post-intake summary, take the perimenopause-staging framing, and ask your doctor to review the peptide list against your current medications and conditions.
We're not asking your doctor to endorse Eterna Femme — only to confirm safety against the rest of your care. The sequencing framework at → /peptides-and-hrt is the cleanest piece to share at that visit, and /perimenopause-stages gives your doctor the staging frame in the same conversation.
It's an education-first site built around research-backed peptide curation for women 40+ navigating perimenopause and postmenopause. The published guides — perimenopause staging, menopause, the free Primer — exist alongside the clinical-curator intake review.
There is no on-site store for the four core approaches and no subscription to manage; the practice operates on education and clinical oversight, not commerce. → Read how that hangs together, or get the free Primer guide for the longer framing.
Yes — the approaches are calibrated for the post-40 hormonal landscape regardless of cycle phase, and postmenopausal women often see the clearest cellular-health and bone-density fit. Longevity & Cellular Health (Epitalon + MOTS-c) and the KLOW complex are explicit postmenopause fits; Recovery & Vitality and Sleep & Restoration apply wherever the symptom picture leads.
→ Read the menopause entry, place yourself on the staging guide, or read the FAQ written for women 40+.
Already navigating perimenopause or postmenopause? Read the FAQ written specifically for women 40+ — including HRT, thyroid, contraception, and postmenopause timing.
Continue learning
Hand-picked reads that follow from this page — not an algorithmic suggestion.
Female physiology
The four axes of sex difference — receptor expression, body composition, pharmacokinetics, and the HPO-gut-brain axis — that make a male-derived baseline the wrong place to start.
Read →Continuity across stages
How your record, your clinician, and your dose history thread continuously through perimenopause into post-menopause.
Read →Consultation guide
A walkthrough of the four-group intake — cycle phase, symptoms, hormonal history, and goals — and how those answers map to an approach recommendation.
Read →Common starting points
If you’re not sure this page matched what you’re feeling this week, the symptom-first entry at /start-here is where most readers place themselves first.
Sleep
If sleep is the dominant thing on your mind after reading the FAQ, place yourself first with the symptom card.
Start there →Perimenopause
Many FAQ answers sequence against your stage — place yourself in the staging map before going deeper on any one topic.
Start there →Longevity
If healthspan and the substrate are the dominant concern, lead with the longevity card before treating any single symptom.
Start there →